Document Detail

Mineralocorticoid Receptor Antagonists and Cardiovascular Mortality in Patients with Atrial Fibrillation and Left Ventricular Dysfunction: Insights from the AF-CHF Trial.
MedLine Citation:
PMID:  22798522     Owner:  NLM     Status:  Publisher    
BACKGROUND: -Patients with heart failure (HF) and atrial fibrillation (AF) may differ from the larger HF population with respect to comorbidities, including renal impairment, and overall prognosis. Associated cardiorenal interactions may mitigate the effects of pharmacological agents. Our primary objective was to assess the impact of mineralocorticoid receptor antagonists (MRA) on cardiovascular mortality in patients with AF and HF enrolled in the AF-CHF trial. METHODS AND RESULTS: -All 1,376 patients randomized in the AF-CHF trial were included. The median baseline creatinine was 105.2 (Q1 88.4, Q3 125.0) μmol/L and the median estimated glomerular filtration rate (eGFR) was 62.3 (Q1 49.0, Q3 77.2) mL/min/1.73 m(2). Renal function was moderately or severely impaired (i.e., eGFR <60 mL/min/1.73 m(2)) in 46.5% of patients. In multivariable analyses, increased creatinine was associated with worsening HF but not mortality. MRA were prescribed in 44.8% and were independently associated with a 1.4-fold increase in total mortality [HR 1.4, 95% CI (1.1, 1.8), P= 0.005] and 1.4-fold increase in cardiovascular mortality [HR 1.4, 95% CI (1.1, 1.9), P=0.009]. This was driven by an increased incidence of sudden cardiac death [HR 2.0, 95% CI (1.3, 3.0), P=0.001]. CONCLUSIONS: -Renal dysfunction was highly prevalent in patients with AF and HF. MRA were independently associated with an increased incidence of cardiovascular deaths, predominantly of presumed arrhythmic etiology. While these provocative findings merit prospective validation, they underscore the importance of careful monitoring of renal function and electrolytes in patients with AF and HF receiving MRA.Clinical Trial Registration-URL: Unique identifier: NCT00597077.
Eileen O'Meara; Paul Khairy; Malorie Chabot Blanchet; Simon Dedenus; Ole D Pedersen; Sylvie Levesque; Mario Talajic; Anique Ducharme; Michel White; Normand Racine; Jean-Lucien Rouleau; Jean-Claude Tardif; Denis Roy
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-12
Journal Detail:
Title:  Circulation. Heart failure     Volume:  -     ISSN:  1941-3297     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101479941     Medline TA:  Circ Heart Fail     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1 Montreal Heart Institute and Université de Montréal, Montreal, Canada;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Predictors for Neoatherosclerosis: A Retrospective Observational Study from the Optical Coherence To...
Next Document:  Hemodynamic, Hormonal and Renal Effects of (Pro)Renin Receptor Blockade in Experimental Heart Failur...